FDA Selects ArisGlobal’s Next-Generation LifeSphere Safety and Medical Affairs Platform

The U.S. Food and Drug Administration (FDA) has selected Booz Allen Hamilton to support development, modernization, and enhancement of the FDA Adverse Event Reporting System (FAERS). As part of this work, the Agency will deploy ArisGlobal’s LifeSphere MultiVigilance (LSMV) platform to replace part of its current pharmacovigilance system that will intake, triage and process safety reports and make them available for review and analysis.

ArisGlobal Safety Expert to Present “The IoT of Pharmacovigilance: From Concept to Reality with Digital Technologies” at 5th Annual Risk Management and Pharmacovigilance Summit

ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences and APCER Life Sciences the industry preferred end-to-end pharmacovigilance services provider, today globally unveiled the first seamlessly integrated cloud technology and pharmacovigilance services platform. The joint managed services plugs in one of the most critical PV compliance gaps of the pharma industry with proven gold blueprint from 40+ organizations and regulatory bodies in 160 countries.

APCER Life Sciences and ArisGlobal launches Multi-tenant LifeSphere® Safety MultiVigilance, Powered with Cutting-Edge Cognitive Automation Technology, for Global Pharmacovigilance

ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences and APCER Life Sciences the industry preferred end-to-end pharmacovigilance services provider, today globally unveiled the first seamlessly integrated cloud technology and pharmacovigilance services platform. The joint managed services plugs in one of the most critical PV compliance gaps of the pharma industry with proven gold blueprint from 40+ organizations and regulatory bodies in 160 countries.

ArisGlobal to Present at 2nd World Congress on Regulatory Affairs for Medical Devices on “Can Medical Devices Learn from Pharma: Shared Challenges, Similar Opportunities!”

ArisGlobal’s session on July 2 at World Congress on Regulatory Affairs for Medical Devices, “Can Medical Devices Learn from Pharma: Shared Challenges, Similar Opportunities,” will focus on how regulatory information management data can be viewed as an asset, creating opportunities for automation and productivity gains.